PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Filamon LTD
Neonc Technologies, Inc.
M.D. Anderson Cancer Center
Assistance Publique - Hôpitaux de Paris
Essen Biotech
Essen Biotech
Institute of Cancer Research, United Kingdom
Tango Therapeutics, Inc.
Institute of Cancer Research, United Kingdom
M.D. Anderson Cancer Center
Mianyang Central Hospital
University of Miami
Turning Point Therapeutics, Inc.
University of Arizona
Jonsson Comprehensive Cancer Center
Duke University
Aveta Biomics, Inc.
LigaChem Biosciences, Inc.
Shenzhen Geno-Immune Medical Institute
Hemerion Therapeutics
Rznomics, Inc.
Cedars-Sinai Medical Center
Université de Sherbrooke
Centre Antoine Lacassagne
Northwell Health
Northwell Health
Northwell Health
Plus Therapeutics
Emory University
Universität Münster
SignPath Pharma, Inc.
The Methodist Hospital Research Institute
The Methodist Hospital Research Institute
Essen Biotech
Queensland Institute of Medical Research
University of Zurich
Philogen S.p.A.
Philogen S.p.A.